Literature DB >> 18778558

The symptomatic relief of dyspnea.

Giovanni Elia1, Jay Thomas.   

Abstract

Dyspnea is a common symptom that causes considerable suffering in cancer patients. Although some knowledge of the sensory information that is transduced to the brain during dyspnea exists, we still have only a rudimentary understanding of the subjective perception of this symptom. There appear to be many parallels between pain and dyspnea. Consistent with this fact, there is growing evidence that opioids are safe and effective and should be considered front-line therapy for symptomatic relief of dyspnea. In addition to opioids, there are other important pharmacologic and nonpharmacologic tools with varying degrees of support that can be considered for symptomatic relief. Importantly, because dyspnea is a subjective symptom that occurs in a unique individual, the optimal treatment of dyspnea will always entail an understanding of, and support for, a patient's other sources of psychosocial, spiritual, and/or existential suffering.

Entities:  

Mesh:

Year:  2008        PMID: 18778558     DOI: 10.1007/s11912-008-0050-7

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN: 1523-3790            Impact factor:   5.075


  68 in total

1.  Central processing of rectal pain: a functional MR imaging study.

Authors:  M V Baciu; B L Bonaz; E Papillon; R A Bost; J F Le Bas; J Fournet; C M Segebarth
Journal:  AJNR Am J Neuroradiol       Date:  1999 Nov-Dec       Impact factor: 3.825

2.  Correlation of regional cerebral blood flow and change of plasma sodium concentration during genesis and satiation of thirst.

Authors:  D Denton; R Shade; F Zamarippa; G Egan; J Blair-West; M McKinley; P Fox
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

Review 3.  A systematic review of the use of opioids in the management of dyspnoea.

Authors:  A-L Jennings; A N Davies; J P T Higgins; J S R Gibbs; K E Broadley
Journal:  Thorax       Date:  2002-11       Impact factor: 9.139

4.  The impact of emotions on the sensory and affective dimension of perceived dyspnea.

Authors:  Andreas von Leupoldt; Corinna Mertz; Sarah Kegat; Swantje Burmester; Bernhard Dahme
Journal:  Psychophysiology       Date:  2006-07       Impact factor: 4.016

Review 5.  Lung opioid receptors: pharmacology and possible target for nebulized morphine in dyspnea.

Authors:  S E Zebraski; S M Kochenash; R B Raffa
Journal:  Life Sci       Date:  2000       Impact factor: 5.037

6.  Can a standardized acupuncture technique palliate disabling breathlessness: a single-blind, placebo-controlled crossover study.

Authors:  George T Lewith; Philip Prescott; Carol L Davis
Journal:  Chest       Date:  2004-05       Impact factor: 9.410

7.  Dyspnea in terminally ill cancer patients.

Authors:  D B Reuben; V Mor
Journal:  Chest       Date:  1986-02       Impact factor: 9.410

8.  Effects of bronchoconstriction and external resistive loading on the sensation of dyspnea.

Authors:  O Taguchi; Y Kikuchi; W Hida; N Iwase; M Satoh; T Chonan; T Takishima
Journal:  J Appl Physiol (1985)       Date:  1991-12

9.  The effect of nasal flow on breathlessness in patients with chronic obstructive pulmonary disease.

Authors:  H P Liss; B J Grant
Journal:  Am Rev Respir Dis       Date:  1988-06

10.  Effects of oral morphine on breathlessness and exercise tolerance in patients with chronic obstructive pulmonary disease.

Authors:  R W Light; J R Muro; R I Sato; D W Stansbury; C E Fischer; S E Brown
Journal:  Am Rev Respir Dis       Date:  1989-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.